相关实验视频
Updated: Jul 12, 2026

07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
编码为adenylyl cyclase VI的腺病毒的冠心内输送增加了左心室功能和cAMP产生能力
1San Diego VA Healthcare System, Department of Medicine, San Diego, CA, USA.
Circulation
|November 9, 2000
概括
使用编码腺病毒的基因转移可显著改善猪的心脏功能. 这种心脏基因治疗表明左心室功能和心脏输出持续增加,没有副作用.
科学领域:
- 心血管医学 心血管医学
- 基因治疗 基因治疗
- 分子心脏病学分子心脏病学
背景情况:
- 研究了腺环酶VI型 (AC(VI)) 基因转移的潜力,以增强心脏功能.
- 在猪模型中利用重组腺病毒进行冠状动脉内输送AC ((VI).
研究的目的:
- 测试一下注射编码AC(VI) 的冠状腺病毒能改善心脏功能的假设.
- 评估AC(VI) 基因转移对心脏表现的有效性和持续时间.
主要方法:
- 评估左心室 (LV) dP/dt和猪心脏输出在冠状腺病毒编码AC(VI) 或lacZ (对照) 的冠状腺病毒输送后.
- 在基因转移之前和之后对 катехоламин刺激 (异二醇,NKH477) 的评估心脏功能反应.
- 通过LV同质化分析确认了转基因表达和功能,用于AC(VI) 蛋白和cAMP生产.
主要成果:
- AC(VI) 基因转移导致LV dP/dt峰值和心脏输出显著增加,持续至少57天.
- 接受lacZ腺病毒的对照动物在心脏功能上没有变化.
- 增加的cAMP产量和AC(VI) 蛋白质含量证实了成功的转基因表达和功能,增加的cAMP产生能力持续长达18周.
- 基本心率,血压或心律失常没有显著变化.
结论:
- 编码为AC(VI) 的腺病毒的冠状动脉内输送可以持续改善心脏功能.
- 这种心脏基因治疗方法在提高心肌功能方面表现出有效性和耐用性.
相关概念视频
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

